ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,081 | +55.6% | 121,792 | +143.9% | 0.00% | 0.0% |
| Q2 2023 | $248,187 | -11.5% | 49,937 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $280,469 | -77.7% | 56,775 | -71.7% | 0.00% | -80.0% |
| Q4 2022 | $1,260,290 | -52.6% | 200,364 | -18.7% | 0.01% | -61.5% |
| Q3 2022 | $2,660,000 | +8.4% | 246,322 | -8.5% | 0.01% | +30.0% |
| Q1 2022 | $2,454,000 | +515.0% | 269,320 | +1605.4% | 0.01% | +233.3% |
| Q4 2020 | $399,000 | +79.7% | 15,792 | +167.7% | 0.00% | 0.0% |
| Q3 2020 | $222,000 | -84.3% | 5,900 | -89.2% | 0.00% | -62.5% |
| Q4 2019 | $1,418,000 | +508.6% | 54,596 | +538.8% | 0.01% | +300.0% |
| Q3 2019 | $233,000 | -16.5% | 8,547 | -17.8% | 0.00% | -33.3% |
| Q2 2019 | $279,000 | -25.8% | 10,401 | -20.0% | 0.00% | -25.0% |
| Q1 2019 | $376,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |